Text this: OPTIMIZATION OF LEVOTHYROXINE THERAPY BASED UPON COMPLEX EVALUATION OF HORMONAL AND IMMUNE STATUS IN THE PATIENTS WITH SUB-CLINICAL AND MANIFESTING HYPOTHYREOSIS